ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Atazanavir-Mepha 150mg, Kapseln - 60
66339001 Mepha Pharma AG
Atazanavir-Mepha 150mg, Kapseln19.09.2017
  19.09.2017
Atazanavir (J05AE08) 
WHO-DDD 
08.03.60
08.03. 
A  
No 
IPCI
PR  
k.A.PR
  
7680663390019Synthetika
  
Composition
atazanavirum 150 mg ut atazanaviri sulfas, lactosum monohydricum 67.203 mg, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDose
Atazanavir150 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Ammoniae Solutio28  
Crospovidonum  
E 132 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Lactose Monohydrate67.203 mg 
Magnesii Stearas  
Per Centum  
Pro Capsula  
Propylenglycol  
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home